Xencor Articles
News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition
17 January 2013
Boehringer Ingelheim links with Xencor on MAb supply
23 February 2012
Amgen and Xencor ink $500 million option pact to co-develop novel antibody for autoimmune diseases
7 January 2011
Showing 1-3 of 3 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
